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Background and Purpose: Cerebral edema and elevated intracranial pressure (ICP)
are the leading cause of death in the first week following stroke. Despite this, current
treatments are limited and fail to address the underlying mechanisms of swelling,
highlighting the need for targeted treatments. When screening promising novel agents,
it is essential to use clinically relevant large animal models to increase the likelihood
of successful clinical translation. As such, we sought to develop a survival model of
transient middle cerebral artery occlusion (tMCAO) in the sheep and subsequently
characterize the temporal profile of cerebral edema and elevated ICP following stroke in
this novel, clinically relevant model.
Methods: Merino-sheep (27M;31F) were anesthetized and subject to 2 h tMCAO
with reperfusion or sham surgery. Following surgery, animals were allowed to recover
and returned to their home pens. At preselected times points ranging from 1 to
7 days post-stroke, animals were re-anesthetized, ICP measured for 4 h, followed
by imaging with MRI to determine cerebral edema, midline shift and infarct volume
(FLAIR, T2 and DWI). Animals were subsequently euthanized and their brain removed
for immunohistochemical analysis. Serum and cerebrospinal fluid samples were also
collected and analyzed for substance P (SP) using ELISA.
Results: Intracranial pressure and MRI scans were normal in sham animals. Following
stroke, ICP rose gradually over time and by 5 days was significantly (p < 0.0001)
elevated above sham levels. Profound cerebral edema was observed as early as 2 days
post-stroke and continued to evolve out to 6 days, resulting in significant midline shift
which was most prominent at 5 days post-stroke (p < 0.01), in keeping with increasing
ICP. Serum SP levels were significantly elevated (p < 0.01) by 7 days post-tMCAO.
Conclusion: We have successfully developed a survival model of ovine tMCAO and
characterized the temporal profile of ICP. Peak ICP elevation, cerebral edema and
Frontiers in Neuroscience | www.frontiersin.org 1 July 2019 | Volume 13 | Article 587
fnins-13-00587 July 6, 2019 Time: 12:44 # 2
Sorby-Adams et al. ICP Temporal Profile Following Stroke
midline shift occurred at days 5–6 following stroke, accompanied by an elevation
in serum SP. Our findings suggest that novel therapeutic agents screened in this
model targeting cerebral edema and elevated ICP would most likely be effective when
administered prior to 5 days, or as early as possible following stroke onset.
Keywords: intracranial pressure, cerebral edema, stroke, large animal model, blood-brain barrier
INTRODUCTION
Worldwide, over 15 million people suffer a stroke each year, of
which one third will die and one third will remain permanently
disabled as a result (Feigin et al., 2017). Cerebral ischemia initiates
a cascade of interrelated events precipitating brain tissue injury
and cell death (Ayata and Ropper, 2002). Of these secondary
injury processes, increased microvascular permeability and loss
of structural integrity of the blood-brain barrier (BBB) are key
to the development of cerebral edema, a pathological state in
which fluid abnormally accumulates in the extracellular space of
the cerebral parenchyma, resulting in an overall increase in brain
volume. This leads to a subsequent rise in intracranial pressure
(ICP), which has devastating consequences including infarct
expansion, displacement of brain tissue, tonsillar herniation, and
death (Steiner et al., 2001; Raslan and Bhardwaj, 2007; Battey
et al., 2014; Kim et al., 2015).
Stroke patients often exhibit a progressive and slow evolution
of brain injury, with cerebral edema and elevated ICP presenting
some days following initial insult to tissue, most commonly
around 3–5 days following onset (Hewitt and Ellory, 2012).
Despite the devastating impact of cerebral edema and elevated
ICP, however, existing treatments fail to address the underlying
pathophysiology, thereby limiting their efficacy (Battey et al.,
2014). Novel therapies that target the underlying cause of swelling
and prevent the evolution of cerebral edema and elevated ICP are
urgently required to improve post-stroke outcomes. To this end,
our laboratory has identified that the tachykinin neuropeptide
substance P (SP) is a key mediator in BBB dysfunction and
development of cerebral edema following stroke (Turner et al.,
2006, 2011; Turner and Vink, 2012) and traumatic brain injury
(TBI) (Vink et al., 2003; Nimmo et al., 2004; Donkin et al.,
2009; Corrigan et al., 2012). Specifically, SP release leads to
neurogenic inflammation, manifesting following acute central
nervous system (CNS) injury as increased BBB permeability
and the development of cerebral edema. Furthermore, we have
established that blockade of the receptor for SP, the tachykinin
NK1 receptor (NK1-r), reduces both BBB permeability and
cerebral edema in rodent models of stroke (Turner et al., 2011;
Turner and Vink, 2012, 2014) and TBI (Donkin et al., 2009;
Corrigan et al., 2012, 2016), suggesting that this is a common
feature of acute brain injury.
An enhanced understanding of the underlying
pathophysiology of cerebral edema and elevated ICP following
stroke is essential in guiding the development of more effective
therapies, and pre-clinical stroke studies are an essential
step in this process. However, the poor clinical translation
of stroke therapies from the laboratory to the clinic to date
has emphasized the importance of appropriate species and
model selection (Casals et al., 2011). The use of large intermediate
species for these studies is paramount in the pre-clinical phase
to improve translation to the clinic due to similarities in
neuroanatomical structure, such as a large gyrencephalic brain
that is closer in similarity to that of the human compared
with many widely adopted small animal models. In light of
this, a number of large animal species are used as pre-clinical
stroke models, including sheep (Boltze et al., 2008; Wells et al.,
2012, 2015), dogs (Qureshi et al., 2004; Cameron et al., 2008;
Boulos et al., 2011; Christoforidis et al., 2011), pigs (Sakoh et al.,
2000; Watanabe et al., 2007; Platt et al., 2014), and non-human
primates (Nehls et al., 1986; Tagaya et al., 1997; Yuji et al.,
2001; D’Ambrosio et al., 2004; Furuichi et al., 2007), each with
their own inherent advantages and disadvantages (Sorby-Adams
et al., 2018). Although gyrencephalic non-human primates are of
great value in modeling the human condition, the cost, housing
requirements and ethical considerations may preclude their use
in large scale studies. Pigs are a widely used experimental species
in models of cardiovascular (Suzuki et al., 2011; Kamoi et al.,
2014) and TBI studies worldwide (Lighthall, 1988; Pfenninger
et al., 1989; Ross et al., 1994; Duhaime et al., 2000; Manley
et al., 2006), however, the Yucatan mini-pig is not available in
Australia, and the rapidly increasing bodyweight of other strains
can make long-term studies difficult. Sheep are an accessible
experimental species and have been used extensively to model
a number of neurological conditions, including non-accidental
head injury (Sandoz et al., 2012; Anderson et al., 2014), TBI (Vink
et al., 2008; Vink et al., 2017), and Huntington’s Disease (Reid
et al., 2013; Morton et al., 2014). Although sheep have earned
a reputation as unintelligent animals, the evidence is quite to
the contrary, as sheep demonstrate excellent facial recognition,
executive decision making and emotional processing, often
comparable to humans on equivalent tasks (Tate et al., 2006;
Keith et al., 2007; Morton and Avanzo, 2011). Specifically, the
high proportion of white to gray matter in the sheep brain
is of particular benefit when studying the pathophysiology of
edema and ICP, given that edematous fluid accumulates in the
white matter following ischaemic stroke (Jha, 2003; Mahajan
and Bhagat, 2016). The strong fibrous tentorium cerebelli of
the sheep, comparable with that of the human, also prevents
the brain from moving downward to accommodate increased
volume of the edematous brain, resulting in persistent elevations
in ICP, midline shift and tonsillar herniation all of which are
seen clinically. Additional advantages of large animal models,
is the ability to take multiple serum and cerebrospinal fluid
(CSF) samples from an individual animal over time which is
not possible in rodents, as well as using clinical physiological
monitoring equipment and magnetic resonance imaging (MRI).
As such, large animal stroke models, including the sheep, are
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an excellent additional screening tool following evaluation in
rodents prior to progression to clinical trials.
There are two models of ovine middle cerebral artery
occlusion (MCAO) currently in use (Boltze et al., 2008; Wells
et al., 2012) both of which involve permanent occlusion of the
MCA. In the Boltze model (Boltze et al., 2008) the craniotomy
is left open so that animals are effectively given decompression
at the time of stroke, allowing for the investigation of long-term
time-points without premature mortality, although intracranial
pressure dynamics cannot be investigated. Conversely, in the
Wells model (Wells et al., 2012, 2015) the craniotomy is
closed following MCAO so that the evolution of ICP can be
accurately studied. However, survival time-points beyond 24 h
are not possible in this model due to the resulting malignant
MCA infarction and ethical requirement to maintain animals
under anesthesia for the duration of the experiment. As such,
there is a clear requirement for an ovine MCAO stroke model
where the MCA is temporarily occluded to study the effects of
reperfusion injury and longer time-points following stroke onset.
Furthermore, there is an increasing incidence of patients who
successfully recanalize following stroke onset. This is largely due
to the increased use of endovascular clot retrieval for reperfusion
of large strokes, such as occlusion of the internal carotid artery
(ICA) or M1 segment of the MCA (Goyal et al., 2016). The
mechanical recanalization of the MCA able to be produced
in a transient MCAO model closely aligns with the vascular
reperfusion achieved with endovascular thrombectomy, and thus
may be more representative of the human condition.
Accordingly, the aims of the present study were to: (1) develop
a survival model of ovine MCAO stroke with reperfusion; (2)
characterize the temporal profile of intracranial pressure changes
following stroke; and (3) determine the contribution of SP to BBB
permeability and cerebral edema that develops in this model. By
determining the clinical course of ICP in this model, an optimal
time window for administration of novel therapeutic agents
targeting elevated ICP due to cerebral edema can be established.
MATERIALS AND METHODS
Experimental Design
A total of 58 (n = 27M;31F) merino sheep (weight range
65 ± 7 kg; age 18–36 months) were used in this study. Animals
(3M and 3F/time point) were pre-operatively randomized to
daily post-stroke survival time points ranging from 1–7 days.
Animals allocated to the post-stroke time-points underwent two
surgeries: tMCAO surgery with recovery, and ICP monitoring
on the designated day post-stroke. An additional group of
animals underwent the surgical procedure without MCAO and
acted as sham controls (n = 4F). These animals had ICP
continuously recorded for 4 h immediately following the sham
surgical procedure. Finally, an additional follow up cohort of 12
animals (n = 6F;6M) underwent stroke surgery and were included
to obtain serum and CSF samples over the 7-day post-stroke
time-course. This was not possible in the main stroke cohort due
to the risk that repeat CSF sampling might potentiate changes
in intracranial dynamics leading to inaccurate measurements
of ICP. All animals were group housed in conventional sheep
paddocks for a minimum of 2 weeks prior to surgery to allow for
acclimatization. Animals were then moved to individual indoor
pens 48 h prior to surgery and fasted over night for a minimum
of 12 h prior to the procedure.
Experimental Procedure
Animal Preparation and Anesthesia
Anesthesia was induced with a combination of intravenous
ketamine (0.05 ml/kg, 100 mg/kg Injection, CEVA, Australia)
and diazepam (0.08 ml/kg, 5 mg/ml Injection, Pamlin, CEVA,
Australia). Following induction, animals were intubated via
endotracheal tube insertion to ensure airway patency for
ventilation. Animals were then positioned on the operating
table on their left side, with hind limbs exposed for arterial
access. An arterial catheter was inserted in the left hind leg for
blood gas sampling and a cannula inserted into the external
jugular vein for fluid and drug administration. Intraoperative
anesthesia was maintained via a combination of inhalational
isoflurane (Henry Shein, Australia; 1.5–2.0%) in 100% oxygen
and intravenous (jugular) ketamine at an infusion rate of
4 mg/kg/h. Crystalloid fluids were administered throughout
surgery via continuous intravenous infusion with compound
sodium lactate (Baxter Health, Australia) to assist hydration and
ionic balance. In addition, intraarterial sodium chloride (Baxter
Health, Australia) was infused at a rate sufficient to ensure arterial
catheter patency. Following surgery, animals were recovered
and treated with subcutaneous antibiotic Rilexine (1 ml/10 kg
every 12 h, 15 g/100 ml Cephalexin, VIBRAC, Australia),
NSAID Carprieve (0.7 mg/kg, 50 mg/ml every 12 h, Carprofen,
Norbrook, Australia) and opioid Temgesic (1.0 ml, 324 ug/ml
Buprenorphine hydrochloride, one dose post-operatively, Reckin
Benckiser, Australia) for pain relief. Antibiotic and NSAID
treatment was continued for a minimum of 3 days following
surgery, with additional opioid and/or NSAID administered as
required thereafter for pain management.
Surgical Approach
A model of ovine stroke was modified from previously published
works (Wells et al., 2012, 2015) in order to achieve tMCAO with
reperfusion (Figure 1). This modification enabled the recovery
of animals from surgery and the study of longer time-points
(beyond 24 h) following stroke. In this particular approach, it
was necessary to keep the coronoid process of the mandible
intact and preserve the surrounding temporalis muscle to ensure
animals were able to masticate following surgery. To achieve
this, a 50 mm curved horizontal incision was made posterior
to the orbital rim of the right eye and terminating anterior to
the ear. Upon incision, the temporalis muscle was retracted and
the coronoid process elevated to expose the underlying skull.
Cervical retractors (Codman) were inserted and blades adjusted
to provide space for a small craniotomy to be drilled at the
junction of the parietal and squamous temporal bones with a
high-speed pneumatic drill using a 5 mm cutting burr (Midas
Rex, Medtronic, MN, United States). Following craniotomy, a
horse shoe durotomy was performed, the brain exposed and
the anterior temporal lobe gently retracted to expose the right
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FIGURE 1 | Surgical approach to ovine transient MCAO. Surgical approach (A), showing site of incision (1; black dashed line) posterior to the orbital rim (2) and
superior to the coronoid process (3). This approach enabled the skull base to be accessed without disrupting the coronoid process or zygomatic arch (5), allowing
for craniotomy (4) and direct access to the MCA, whilst ensuring post-operative recovery of the animal and the ability to masticate following the procedure. Superior
view of craniotomy site (B) showing the aneurysm clip applied to the proximal MCA.
proximal MCA. A small amount of CSF was aspirated to ensure
sufficient visualization of the proximal MCA, however, this
was kept to a minimum to reduce the impact on intracranial
volume. Gentle dissection of the MCA from the arachnoid
mater was performed to allow for a temporary aneurysm clip
(Aesculap) to be applied proximal to the MCA bifurcation using
a clip applicator (YASARGIL Aneurysm clip system, Aesculap).
Successful clipping of the MCA resulted in an immediate decrease
in vessel caliber, confirming reduced blood flow. The dura was
then gently re-opposed onto the brain and the craniotomy site
filled with sterile saline to prevent dehydration of the underlying
cortical tissue and the surgical site draped. The clip was left
in situ for 2 h and subsequently removed with clip applicators
to achieve reperfusion. Visual confirmation of reperfusion was
noted when the caliber of the vessel increased and blood returned
to the distal MCA. Successful reperfusion also was confirmed on
magnetic resonance angiography (MRA) MRI performed at the
pre-selected timepoints.
Following reperfusion, the dura was approximated and
interleaved with synthetic dura (Durepair, Medtronic, Australia)
to cover the exposed brain. Dural closure was then achieved
with ethyl cyanoacrylate (Bostik, Australia), and the bone
previously removed reinserted into the craniotomy site and
reinforced with dental acrylic cement (Sledgehammer, Keystone,
Germany) to create a watertight seal, thus restoring intracranial
dynamics. The surgical site was then treated with 1.0 ml 0.5%
local anesthetic Marcain (bupivacaine hydrochloride 5 mg/ml,
AstraZeneca, Australia) and closed using a 0.1 Vicryl braided
polyglactin Suture (ETHICON, Australia) using the horizontal
mattress suture technique of wound closure to minimize
risk of infection. The animal was removed from anesthesia,
extubated and pain relief administered prior to transfer into
a post-operative recovery pen. Mean arterial blood pressure
(MABP) was monitored at 5-min intervals throughout surgery
via application of a pediatric blood pressure cuff (Delfi Medical,
Canada) on the upper left front limb. Blood gas samples (Machine
AVL Scientific Corporation United States, Manufactured by
Hersteller, OPTI Critical Care Analyzer–Model OPTI3, Serial No.
OP3-2759) were acquired hourly via arterial catheter sampling
to determine pO2, pCO2, hematocrit, hemoglobin, pH, Na+
and K+ levels. End tidal CO2 was also recorded at regular
intervals. Animals were maintained on a heating pad throughout
all surgical procedures and rectal temperature checked hourly to
ensure maintenance of body temperature within normal ovine
limits (37.5–39.0◦C).
ICP Measurement
At 4 h prior to the pre-determined post-stroke time-point, or
immediately following surgery in shams, anesthetized (using
aforesaid isoflurane and ketamine maintenance protocols)
animals were placed prone in the sphinx position on the
operating table. Bilateral burr holes were drilled into the left
and right parietal bones, posterior to the coronal suture and
approximately 20 mm from the sagittal suture. The dura was
perforated and skull bolts secured, following which Codman
microsensor ICP probes (Codman Neuro, DePuy Synthes,
Australia) were inserted to an approximate depth of 15 mm
into the brain parenchyma and ICP recorded continuously for a
period of 4 h post-MCAO induction or sham surgery (LabChart
Reader, ADInstruments, v. 8.1.1). Two-point calibration (0 and
100 mmHg) was performed prior to insertion of probes and at the
end of the recording period to confirm measurement accuracy.
ICP readings selected for final analysis (left or right) were based
on calibration data, with readings preferentially selected from the
right hemisphere probe. Raw ICP data underwent a logarithmic
exponential transformation as previously described and was
expressed as geometric mean ± SEM (Matthews et al., 1990;
Wells et al., 2015).
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MRI
Following the 4-h ICP monitoring period, animals were moved
to a 1.5T Siemens Syngo2004A (Siemens AG, Munich, Germany)
MRI scanner, during which they were maintained under general
anesthesia (3% isoflurane). Sequences were acquired including
time-of-flight MRA (TOF MRA; TR 26 ms, TE 3.69 ms, slice
thickness 0.50 mm), diffusion weighted imaging (DWI; TR
5600 ms, TE 80 ms, slice thickness 3.0 mm), fluid attenuated
inversion recovery (FLAIR; TR 5000 ms, TE 386 ms, slice
thickness 0.9 mm), T1-weighted imaging (TR 2300 ms, TE
2.58ms, slice thickness 0.9 mm) and T2-weighted imaging
(TR 3200 ms, TE 410 ms, slice thickness 0.9 mm). T1-
weighted post-contrast images were also acquired following
intravenous administration of 1 mL/kg gadolinium-diethylene-
triamine-pentaacetic acid (GAD) (Magnevist, Bayer HealthCare,
Germany) to determine the extent of BBB breakdown on MRI.
The degree of midline shift was used as a surrogate marker for
the anatomical sequalae of cerebral edema. Shift from the midline
was assessed using axial T2-weighted scans and measured in
mm from the septum pellucidum at the level of the foramen
of Monro (Horos DICOM image viewer v3.1.1). To calculate
cerebral edema, coronal FLAIR images were analyzed using
Horos DICOM image viewer (v3.1.1). After optimal adjustment
of brightness and contrast, edema volume was determined
from sequences using computer-aided manual tracing of the
hyperintense lesion by a blinded assessor. The areas were then
summed and multiplied by the slice thickness to give a total
volume in cm3.
To calculate infarct volume, segmentation tools in ITK-
SNAP (v3.7) were used to perform semi-automated segmentation
of the MRI diffusion lesions using diffusion-weighted images
(Yushkevich et al., 2006). A combination of “three-dimensional
active contour segmentation” and subsequent manual post-
processing of the segmentation while adjusting image thresholds
was performed to maximize reproducibility whilst excluding
artifacts. The “three-dimensional active contour segmentation”
consisted of multiple steps: First, in the pre-segmentation phase,
independent component analysis automatically segmented parts
of the DWI image and these were manually identified as
foreground or background. To obtain an optimal distinction
between foreground and background, thresholds of the image
windows were adjusted. After thresholding, a “speed image” with
a separate foreground and background was created. Next, in
the active contour phase, seed regions were manually placed
within the region of interest (ROI). These seeds were then
automatically grown within the ROIs to form the temporary
segmentation. Subsequently, areas that were not automatically
included in the “active contour segmentation,” were manually
included in the follow-up infarct segmentation. The total
volume of the segmentation was exported and reported in
cm3 for analysis.
Perfusion and Histological Examination
Following MRI, intravenous heparin (5000 I.U./5 ml; Pfizer,
NY, United States) was administered and animals humanely
euthanized via common carotid perfusion fixation with
cold TRIS-buffered saline under isoflurane anesthesia. The
brains were subsequently removed and sliced into 10 mm
coronal slices using a custom-made sheep brain matrix.
Sections were then immersion fixed in 10% neutral-buffered
formalin for a minimum of 14 days prior to being processed,
embedded in paraffin wax and sectioned coronally at 5-
micron intervals to identify albumin, SP, and caveolin-1 via
immunohistochemistry (Table 1).
Serum and CSF Collection
Blood samples were collected (BD-Vacutainer R©-SSTTM-II-
Advance-Tube) from animals (n = 12, 6M;6F) pre-injury
and at 4, 8, 12, and 16 h post-stroke and on days 1, 3, 5,
and 7 via jugular venipuncture. Following collection, samples
were centrifuged (10 min at 2000g) and serum extracted into
10 × 500 µl aliquots and stored at −80◦C. CSF was collected
via lumbosacral tap prior to induction of stroke and on days
1, 3, and 6 thereafter. Note that this was performed in the
follow up cohort, and these animals did not undergo ICP
monitoring so there were no concerns regarding multiple CSF
draws and the associated effects on ICP measurement accuracy.
Prior to collection, animals were induced with combination
diazepam and ketamine as previously described. The animals
were then placed in the prone position on a surgical table
and the sagittal plane of the animals vertebrae manipulated
so that it was perpendicular with the horizontal plane of the
bench. The animal was shaved to allow for clear access to the
lumbosacral joint and appropriate visualization for landmarks.
Palpation of the hips was performed to determine the correct
sagittal plane orientation of the spine and the optimal site for
CSF collection was determined via identification of the midline
depression between the last lumbar and first sacral vertebrae.
The area was cleaned using a 4% chlorhexidine preoperative
surgical scrub brush (BD E-Z ScrubTM), povidone-iodine applied
and site surgically prepared. A steriseal spinal needle with
stylet (Becton Dickinson Medical Technology) was inserted
perpendicular to the skin and the needle advanced slowly
through the subcutaneous tissue and interarcuate ligament
until a sudden drop in resistance was felt indicating the
advancement through the dural membrane and entry into the
subarachnoid space. The stylet was then removed and 2 ml of
CSF aspirated via a syringe and deposited into a 3 ml container;
sample placed immediately on ice for 20 min, centrifuged
(15 min at 3000g), extracted into 3 × 500 µl aliquots and
stored at−80◦C.
Analysis of Serum and CSF
Serum and CSF samples were used to quantify expression
of SP using enzyme-linked immunosorbent assay (ELISA)
TABLE 1 | Immunohistochemistry protocols.
Antibody Dilution Retrieval Brand Catalog no.
Albumin 1:2000 No retrieval Dako A0001
SP 1:5000 Citrate Abcam ab14184
Caveolin-1 1:500 EDTA Cell Signaling
Technologies
3238
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according to the manufacturer’s instructions (Abcam;
KIT-ab133029). All samples were diluted 1:4 in assay buffer
for appropriate compliance with each individual plate
standard curve. Standards, serum and CSF test samples
were run and the plate immediately analyzed following
addition of the stop solution using a spectrophotometric
microplate reader (Synergy HTX, multi-mode reader). At
optical density of 405 nm light absorbance was calculated to
give an inverse reading of SP proportional to its captured
measure on the plate.
Statistical Analysis
All data are expressed as mean ± SEM. Physiological data
(MABP, pH, pO2, and pCO2) were analyzed using one-
way analysis of variance (ANOVA) followed by Tukey’s
post hoc tests (Prism v.8.0.1, Graphpad, CA, United States).
ICP, infarct volume, cerebral edema and midline shift
data were analyzed by one-way ANOVA with multiple
comparisons followed by Tukey’s post hoc tests. ELISA
evaluation was performed for each plate using individually
generated standard curves and an R-value of 0.9709 was
accepted to improve the efficacy of inter-plate accuracy.
ELISA values were then analyzed via one-way ANOVA with
Tukey’s post hoc. Pearson’s correlations were run between
midline shift and cerebral edema, cerebral edema and ICP
and midline shift and ICP to determine the relationship
between variables. A two-way ANOVA with Sidak’s multiple
comparison test was run to determine gender differences
in physiological variables during both surgery and ICP
monitoring. Gender discrepancies were also established for
infarct volume, cerebral oedema, midline shift and ICP in
addition to CSF and serum SP via two-way ANOVA with
Sidak’s post hoc. A p-value < 0.05 and R-value > 0.04 was
considered significant.
RESULTS
Surgery, Mortality, and Post-operative
Course
There was no premature mortality of animals in the present
study. One animal was excluded due to insufficient reperfusion
following MCAO as seen on MRA, resulting in a permanent
rather than a transient occlusion (Figure 2). In all other
temporary occlusions of the MCA reperfusion was successfuly
achieved and confirmed on MRA. A further four animals
were excluded due to significant anesthetic difficulties which
confounded the experimental course (n = 2 in 2 days group;
n = 2 in 3 days group). Specifically, the excluded animals
were unstable throughout the induction of stroke surgery,
necessitating repeat boluses of ketamine and diazepam and
an increased rate of isoflurane to maintain surgical levels
of anesthesia, which resulted in significantly lowered MABP,
decreased cerebral perfusion pressure and ultimately profound
infarct expansion.
All animals were able to use their jaw and masticate to
eat following surgery. A comprehensive behavioral analysis
was beyond the scope of this study, however, all animals
in the ICP cohort were observed for jaw alignment and
eating behavior, the presence/absence of fetlock weakness and
demeanor throughout the post-stroke period. A total of 9/42
animals demonstrated evidence of jaw misalignment following
stroke surgery, which persisted to the end of the experiment
in 3/9 animals. Although 25/42 animals showed reduced
food intake post-stroke when compared to their pre-stroke
daily intake, body weight remained within acceptable limits
(< 15% reduction from pre-stroke weight). A total of 14/42
animals showed fetlock weakness following stroke, manifesting
as knuckling of the distal forelimb which was most commonly
observed on day 1 and typically resolved by day 4 post-stroke.
FIGURE 2 | MCA reperfusion following transient MCAO (A) compared to permanent MCAO (B) on time-of-flight MRA. Evidence of vessel patency, indicated by the
white arrow, following clip removal in transient MCAO animals compared to permanent MCAO animals, where the vessel cannot be visualized MRA (data not
reported). MCA, middle cerebral artery; ACA, anterior cerebral artery; ICA, internal carotid artery; BA, basilar artery; RM, rete mirabile.
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A decline in demeanor, as demonstrated by a lowered head
position and droopy ears, was observed in 26/42 animals
and was most prevalent at days 5–7 post-stroke, coinciding
with elevated ICP.
Physiological Parameters
Physiological variables for pCO2, MABP, and pH were within
normal limits for all groups throughout the duration of the
experiment (Table 2). As animals were maintained on 100%
oxygen (oxygen 6.0 L/min) through the course of surgery and
ICP monitoring this resulted in pO2 values that were significantly
above the normal clinical range of 90–100 mmHg. These
observations, however, were observed across all experimental
groups. No significant difference (p > 0.05; Table 1) in pO2,
pCO2, or pH were observed amongst groups during stroke
surgery or the 4-h period of ICP monitoring. There was however
a statistically significant decrease in MABP during the ICP
monitoring period seen at 1-day post-stroke compared with 4
(p = 0.04) and 7 (p = 0.01) days.
Intracranial Pressure
Intracranial pressure remained within normal limits for the
duration of the 4-h monitoring period in sham animals
(8 ± 2 mmHg). From 1 to 4 days following tMCAO,
ICP levels were comparable to sham (p > 0.05; Figure 3).
However, by 5 days post-stroke, ICP was significantly elevated
(28 ± 10 mmHg; p < 0.0001) from sham levels and post-stroke
days 1–4 (p < 0.0001). ICP remained significantly elevated out
to 6 days post-stroke when compared to shams (25 ± 5 mmHg;
p = 0.0001) and 1 (p = 0.0001), 2 (p = 0.0003), 3 (p = 0.03) and
4 day (p = 0.0007) post-stroke time points. By 7 days, ICP began
to decline (18 ± 2 mmHg; p = 0.02 when compared to 5 days),
but remained significantly elevated compared to sham (p = 0.04),
although not significantly different (p > 0.05) from recordings on
days 1, 2, 3, 4, and 6 post-stroke.
MRI
Magnetic resonance imaging was normal in sham animals, with
no evidence of infarction, cerebral edema or midline shift (data
not shown). At each time-point following stroke there was
evidence of MCA recanalization following clip removal as seen
on MRA, with the aforementioned exception of one animal that
was excluded due to persistent MCAO (Figure 3). All stroke
animals showed evidence of hyperintensity on T2-weighted and
FLAIR images in the territory MCA, indicative of the infarct core
and surrounding extracellular edema (Figure 4). There was no
significant difference in infarct volume at any of the time points
post-stroke as measured on DWI MRI (Figure 5A).
Cerebral edema evolved over time from 1 to 6 days
post-tMCAO, with the largest volume of cerebral edema seen
at 5 (8.86 ± 2.03 cm3) and 6 days (7.01 ± 0.9 cm3).
This increase in the volume of edema was accompanied by
increased extravasation of GAD across the barrier, as seen in T1
post-contrast sequences, indicative of BBB breakdown (Figure 4).
However, although a qualitative evolution of cerebral edema
post-stroke was apparent (Figure 4), accompanied by increased
GAD contrast, there was no statistically significant difference
FIGURE 3 | Temporal profile of ICP following transient MCAO. ICP was
significantly elevated at 5 days (p < 0.001) and 6 days (p < 0.05) post-stroke
when compared to sham. By 7 days, ICP began to resolve though remained
elevated compared to sham (p < 0.05). ∗∗∗∗p < 0.0001; and ∗∗∗p < 0.001
compared to sham. n = 6/time-point, n = 4 sham.
between time-points (Figure 5B; p > 0.05). Midline shift was
evident in all stroke animals, the degree of which evolved over
time following stroke (Figure 5C) and was most prominent
at 5 days post-stroke (3.92 ± 0.59 mm) when compared to 1
(p = 0.002) and 7 days (p = 0.04), in keeping with ICP findings.
No animals showed evidence of tonsillar herniation or brain stem
compression on MRI (data not shown).
Despite the fact that cerebral edema findings were not
significantly different between time points, there was a moderate
positive correlation seen between midline shift and cerebral
edema calculations (r = 0.49; Figure 6A). However, there
was no positive correlation seen between ICP and cerebral
edema (r = 0.23; Figure 6B) or ICP and midline shift
(r = 0.20; Figure 6C).
SP ELISA
A reduction in serum SP was observed between 4 and
16 h following transient MCAO, however, changes were not
significant (p > 0.05; Figure 7). At 7-days post-stroke, SP levels
were significantly elevated compared to 16 h (p = 0.002) and days
1 (p = 0.04), 4 (p = 0.04), 8 (p = 0.008) and 12 (p = 0.003) following
occlusion. Despite a qualitative increase, the concentration of
serum SP at day 7 was not significantly elevated (p > 0.05) when
compared to pre-stroke measurements. Furthermore, despite
a relative increase in SP seen in the serum post-stroke, no
significant changes (p > 0.05) in SP levels in the CSF (Figure 7)
were observed at any time-point following MCAO.
Gender Comparisons
No differences in pCO2, pO2, MABP or pH were seen between
sexes during either stroke surgery or ICP monitoring (p > 0.05;
Table 2). There was no significant difference in ICP between
male and female animals at any of the post-stroke time-points
(p = 0.93; Figure 8A). Furthermore, there was no significant
difference in infarct volume (p = 0.79; Figure 8B), cerebral edema
(p = 0.41; Figure 8C) or midline shift (p = 0.39; Figure 8D)






















TABLE 2 | Surgical and intracranial pressure monitoring physiological parameters.
Surgery day ICP monitoring Surgery day ICP Monitoring
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FIGURE 4 | MRI findings following transient MCAO. Cerebral edema, as
shown in coronal FLAIR MRI images, evolved from 1–6 days following stroke,
beginning to resolve by 7 days. This evolution in cerebral edema was
associated with enhanced extravasation of GAD across the BBB as seen on
T1 weighted post-contrast series (T1+GAD) when compared to pre-contrast
T1 series. Lesion volume, as shown in DWI MRI images, was comparable
across time-points following stroke.
seen between sexes following stroke. SP levels in the serum were
not significantly different between males and females (p = 0.41;
Figure 8E). However, there was a significant increase in SP seen
in the CSF (Figure 8F) of females when compared to males pre-
stroke (p = 0.002), and at 1 (p < 0.0001), 3 (p < 0.0001) and 6
(p = 0.002) days post-stroke although there were no significant
within group differences observed in the females at any time-
point pre- or post-stroke (p = 0.18).
Immunohistochemistry
Albumin
There was minimal evidence of albumin extravasation
in sham tissue (Figure 9). Following stroke, marked
albumin extravasation, indicative of BBB breakdown and
subsequent vasogenic cerebral edema formation, was observed
both macroscopically within the infarcted territory and
microscopically in the perivascular tissue of the infarct, most
prominent of which was at 5 and 6 days post-stroke.
SP
Little to no perivascular SP immunoreactivity was observed
in sham tissue (Figure 10, Substance P, S). Following stroke,
a marked increase in perivascular SP immunoreactivity was
observed in tissue at 5 and 6 days, which was still evident at 7 days,
although less pronounced.
Cav-1
Low levels of caveolin-1 immunoreactivity were observed
in sham tissue (Figure 10, Caveolin-1, S). Following stroke,
an increase in perivascular caveolin-1 immunoreactivity
was identifiable which was particularly evident at 5 and
6 days post-stroke.
DISCUSSION
This study is the first to describe a surgical approach to
ovine tMCAO with reperfusion. Through this study we have
successfully developed a model that conserves tissue and permits
post-operative recuperation, allowing for investigation into
the pathophysiology of ischemic stroke, in particular post-
stroke complications such as BBB disruption, development of
cerebral edema and elevated ICP. This method of transient
stroke induction provides a clinically relevant model in
which promising novel treatments targeting stroke and its
complications can be screened.
Although a number of studies have reported raised ICP
following stroke in small animal models (Beard et al., 2015;
Murtha et al., 2015) and large animal species at early time-points
(Wells et al., 2015) this study is the first in which ICP was
recorded out to 7 days post-stoke in a large gyrencephalic
species. Using this model we have successfully characterized
the temporal profile and established that ICP peaks at 5–
6 days following ovine transient MCAO. These findings are
comparable to the human patients, where ICP is shown
to peak 3–5 days post-stroke, indicating that our model
reliably replicates the clinical situation (Battey et al., 2014).
The modest difference in the time course between the ovine
model and humans may reflect the additional time taken to
restore intracranial dynamics following surgery due to CSF
aspiration required for optimal visualization of the proximal
MCA. Indeed, a closed skull approach to MCAO where ICP
dynamics are maintained through the induction of stroke
may yield a timeline of ICP changes that directly align with
clinical pathogenesis, however, this was not possible due to
the complex ovine extracranial cerebrovasculature, in particular
the rete mirabile, which precludes vascular access via the ICA
for insertion of a balloon catheter, autologous clot or other
occlusive agent.
Regardless, at 5–6 days post-stroke we consistently observed
elevated ICP readings above 20 mmHg. In the clinic, ICP readings
of ≥20 mmHg warrant investigation for possible treatment and
intervention (Lavinio and Menon, 2011; Battey et al., 2014),
as persistently elevated ICP is associated with poor outcome
following ischemic stroke, widely accepted as being attributable
to the development of edema in the cerebral parenchyma
(Ayata and Ropper, 2002). Despite this, conflicting studies have
reported an elevation of ICP in the absence of cerebral edema
following small ischemic stroke in rats (Beard et al., 2015;
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FIGURE 5 | Quantification of infarct volume, cerebral edema, and midline shift on MRI. (A) There was no significant difference (p > 0.05) in infarct volume at any of
the time-points following stroke. (B) The evolution of cerebral edema showed a similar pattern to ICP, however, changes were not significant (p > 0.05). (C) Midline
shift was significantly greater at 5 days when compared to 1 (<0.01) and 7 (p < 0.05) days post-stroke. Data shown as mean ± SEM. ∗p < 0.05 compared to
7 days, ∗∗p < 0.01 compared to 1 day. n = 6/time-point.
FIGURE 6 | Relationship between ICP, cerebral edema, midline shift and infarct volume. There was a moderate positive correlation seen between cerebral edema
and midline shift (r = 0.49, A). Despite this, there was no correlation seen between ICP and cerebral edema (r = 0.23, B), or ICP and midline shift (r = 0.20, C). NB
data from all time points was used for comparison between variables.
FIGURE 7 | Temporal profile of serum and CSF SP levels following stroke. At 7 days post-stroke, SP in the serum was significantly elevated compared with levels
seen at 4 h (p < 0.05), 8, 12, and 16 h (p < 0.01), and 1 day (p < 0.05) following stroke. Furthermore, despite a qualitative increase, SP concentration pre-stroke
was comparable to day 7 post-stroke. In the CSF, there was no significant difference seen in SP levels at days 1, 3, and 6 post-stroke (p > 0.05). Data shown as
mean ± SEM. ∗p < 0.05 compared to 4 h and 1 day; ∗∗p < 0.01 compared to 8, 12, and 16 h. n = 12/time-point serum; n = 8/time-point CSF.
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FIGURE 8 | Sex differences following tMCAO. There was no significant difference in ICP (A) seen between sexes at any of the post-stroke time points (p > 0.05).
Furthermore, there was no significant difference seen between males and females in infarct volume (B), cerebral edema (C), or midline shift (D) (p > 0.05). SP levels
in the serum (E) were not significantly different between sexes (p > 0.05) but were significantly elevated in the CSF (F) of female animals compared to males at both
pre and post-stroke time points (p < 0.01). Data shown as mean ± SEM. ∗∗∗p < 0.01 and ∗∗∗∗p < 0.0001 females compared to males. n = 3/time-point ICP infarct
volume, midline shift and edema; n = 6/time-point for serum; n = 4/time-point CSF.
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FIGURE 9 | Albumin immunoreactivity in sham (S) and post-stroke animals at
1 (1), 2 (2), 3 (3), 4 (4), 5 (5), 6 (6) and 7 days (7) post-stoke. Enhanced
albumin extravasation evolved over time following stroke and was most
prominent at 4–6 days following tMCAO. This pattern of albumin staining was
consistent with perivascular staining seen microscopically. Microscopic
images scale bar 100 µm, 40× magnification.
FIGURE 10 | SP and caveolin-1 immunoreactivity in sham (S) and post-stroke
animals at 1 (1), 2 (2), 3 (3), 4 (4), 5 (5), 6 (6), and 7 days (7) post-stoke. There
was no identifiable immunoreactivity of SP or caveolin-1 in sham animals (S).
Low levels of SP immunoreactivity were seen perivascularly at 1–4 days
post-stroke. At 5 and 6 days following transient MCAO, there was an increase
in SP seen in the perivascular tissue of the ischemic penumbra in the affected
hemisphere. This increase in SP was concordant with an increase in
caveolin-1 immunoreactivity perivascularly, which was most evident at
5–6 days. Arrows indicate increased immunoreactivity of SP and cav-1 seen
surrounding vessels. Scale bar 100 µm, 40× magnification.
Murtha et al., 2015). However, the underlying pathophysiology
of increased ICP was not reported and requires further
investigation. Furthermore, in the case of larger hemispheric
strokes seen clinically, such as that of proximal MCAO or
ICA occlusion, there is a positive correlation between cerebral
edema and elevated ICP (Engelhorn et al., 2002). However,
we did not observe such a relationship in this study, which
may reflect the within group variability and different cohorts
that were required to populate the time course. Furthermore,
when measuring elevated ICP following stroke, the influence
of autoregulation must also be taken into consideration. The
ability to maintain cerebral homeostasis plays an important
role in moderating the pathogenesis of elevated ICP. A loss of
autoregulation has been shown to enhance the progression of
ischemia and development of cerebral edema, and thus plays an
important role during MCA reperfusion (Dohmen et al., 2007).
It is proposed that autoregulation may be enhanced quite early
following stroke, and become dampened at 6 days post-stroke
(Reinhard et al., 2012), in keeping with our observations of
significantly elevated ICP at 6 days post-stroke. Furthermore,
elevated ICP is associated with a decreased ability to autoregulate
following head injury, indicating a strong positive correlation
between the two (Reinhard et al., 2012).
We observed an evolution of cerebral edema over time
following stroke, although changes were not significant between
time-points. Nevertheless, it is widely accepted that the increased
volume of the brain as a result of cerebral edema positively
correlates with subsequent elevations in ICP (Battey et al., 2014;
Beard et al., 2015; Brogan and Manno, 2015). The development
of vasogenic cerebral edema in particular occurs following loss
of integrity of the BBB, permitting the abnormal extravasation
of proteins across the damaged barrier. This creates an osmotic
drive pulling water from the vasculature into the extracellular
cerebral parenchyma, leading to an overall increase in brain
volume and concomitant rise in ICP (Battey et al., 2014).
Our study was able to confirm that there was disruption to
BBB via visualization of the GAD contrast medium within
the brain parenchyma, suggesting that the cerebral edema seen
was vasogenic in nature. This finding was substantiated by the
increased extravasation of albumin following tMCAO, which
was most prominent at 5–6 days post-stroke. Albumin is unable
to cross the intact barrier under physiological conditions due
to its large size and structure (Quinlan et al., 2005). Previous
studies have established that albumin crosses the barrier via
the transcellular pathway, facilitated by caveolae (Abbott et al.,
2006), of which caveolin-1 (cav-1) is an integral component
(Nag et al., 2007). Indeed, increased barrier permeability in
association with caveolin-1 upregulation was observed in the
absence of tight junction breakdown, confirming the integral role
of caveolae in the maintenance of barrier integrity (Povlishock
et al., 1978; Nag et al., 2007). Our IHC findings of increased
cav-1 immunoreactivity at 5–6 days post-stroke corroborate
this, providing a potential mechanism driving sustained barrier
permeability and the evolution of cerebral edema. Furthermore,
the volumetric enlargement of the brain as a result of vasogenic
edema leads to displacement of cerebral tissue and subsequent
shift of the midline, a critical state in which compression
of adjacent brain structures precedes potentially fatal tonsillar
herniation (Huttner and Schwab, 2009). We observed significant
midline shift at 5 days following stroke in keeping with elevated
ICP. As such, our findings of enhanced GAD, albumin and cav-
1 immunoreactivity at 5–6 days post-stroke suggest a loss of
barrier integrity at this time-point, precipitating the development
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of vasogenic cerebral edema, extensive midline shift and the
subsequent rise in ICP seen in this model.
We also demonstrated that serum SP levels were increased
at 7 days following stroke when compared to pre-stroke
values. This followed a non-significant decline in serum SP
at 4 h which continued to decline out to 16 h following
injury. This suggests a peak increase in the levels of serum
SP may occur ahead of the 4 h-post-stroke sampling time-
point. Indeed, rodent TBI studies have reported an early peak
in plasma SP levels at 30 min post-injury but a decline
by 5 h post-injury (Donkin and Vink, 2010) Similarly, SP
levels were increased in serum samples obtained within 12 h
following the onset of both clinical stroke (Bruno et al., 2003;
Lorente et al., 2016) and TBI (Lorente et al., 2015), with
higher levels associated with early mortality. Although some
discrepancy between experimental and clinical time-points exists,
it is important to acknowledge that it is difficult to draw
firm comparisons given the complications in obtaining clinical
samples at acute time-points. We also examined SP levels in
the CSF following stroke, though observed no differences at
1, 3, or 6 day time-points. Although females consistently had
higher CSF SP levels compared to males at all post-stroke
time-points, there was no significant change in these levels
post-stroke. This suggests that females have higher baseline
levels of SP. Indeed, gender differences in the SP response
have previously been observed (Pittenger et al., 2016; Simões
et al., 2018). A comprehensive sampling regime, including
sampling at 4 and 6 days post-stroke for serum and 4 and
5 days post-stroke for CSF, would be required to populate
a detailed time-course of changes in SP in the serum and
CSF in the setting of ischemic stroke, and may reveal changes
beyond those observed in the current cohort. Nevertheless, the
increase in serum SP levels we observed, in conjunction with
the increased barrier permeability and vasogenic edema seen
with albumin IHC and MRI, support a potential role for SP
in the genesis of cerebral edema and development of elevated
ICP in this model. Indeed, our rodent stroke studies support
this (Turner et al., 2006, 2011; Corrigan et al., 2012, 2016;
Turner and Vink, 2012, 2014) and corroborates our recent work
demonstrating the efficacy of NK1-r antagonist treatment in
reducing ICP in an ovine model of permanent MCAO (Sorby-
Adams et al., 2019). Taken together, these findings suggest
that neurogenic inflammation occurs following ischemic stroke
and may contribute to the increased BBB permeability and
elevated ICP observed, suggesting that blocking the action of
SP with a tachykinin NK1-r antagonist may be an effective
strategy to mitigate these post-stroke complications and thus
improve outcome.
LIMITATIONS AND FUTURE DIRECTIONS
Although the findings of this study demonstrate successful
model development and clearly show the evolution of ICP
following stroke, limitations must be acknowledged. It must
firstly be recognized that human patients are rarely under
anesthesia when suffering a stroke. This is of particular
importance due to the implied effects of anesthesia, both
protective and deleterious. Ketamine has been shown to
have neuroprotective effects (Hudetz and Pagel, 2010), whilst
isoflurane is associated with respiratory depression, decreased
MABP and thus diminished oxygen supply to neuronal cells
(Murr et al., 1993), exacerbating cerebral ischemia. These
limitations have been discussed in detail in our previous
studies (Wells et al., 2012, 2015), however, due to the
nature of the surgical procedure, anesthesia is unavoidable
(Lin et al., 1997). The decision to maintain animals on a
combination of ketamine and isoflurane was made on the
basis of prolonged duration (4–5 h) of surgical procedures.
The anesthetic combination produces a countering effect,
eliminating the neuroprotective effect of pure ketamine and the
respiratory distress associated with pure isoflurane, thus reducing
confounding factors of anesthetic agents administered alone
(Schifilliti et al., 2010).
There was a large within group variability, particularly
for the MRI parameters, seen at each of the time-points
following stroke. This may reflect differences in collateral
flow or autoregulation capacity within the individual animals.
Indeed, there is a considerable degree of variation in the
severity and timing of cerebral edema in human patients
following stroke. Furthermore, there may be some variability
due to the severity of stroke in addition to the relative age
of the sheep compared with the greater stroke population.
In this study we used sheep aged 18–24 months, which are
the equivalent to mid-adulthood in humans, whereas clinical
stroke most commonly occurs in those over 60 years of age.
Furthermore, the exclusion of experimental animals due to
anesthetic complications or lack of reperfusion decreased the
total sample size. This could be addressed by increasing the
overall sample size for each group to increase statistical power.
It must also be acknowledged that we used different cohorts
of animals to generate the stroke ICP data, sham ICP data
and serum/CSF for the ELISAs. This led to an inability to
run true correlations between groups, for example between
the SP and ICP datasets, limiting the conclusions we can
draw regarding the potential relationship between serum/CSF
SP and ICP. Furthermore, there was some discrepancy seen
between elevated ICP and edema at 5–6 days in the first
cohort and elevated serum SP seen at 7 days in the second
cohort. Our findings suggest that SP is involved in the
evolution of edema, however, given that different cohorts
used in this study it was difficult to establish a definitive
relationship between the two. As such, the differences in the
time course of SP elevations and increased ICP are most likely
attributable to the different cohorts used for each of these
outcome measures.
In order to reduce the number of animals required we
utilized a cohort of sham animals that underwent sham surgery
immediately followed by ICP monitoring. We acknowledge that
we would have preferentially used the same regime as the stroke
cohort but it was not possible to generate an additional sham
control cohort for this study alone. When measuring ICP, values
would ideally be obtained from the same animal from 1–7 days
post-stroke to look at the evolution of pressure individual
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to that animal. This could be addressed through the use of
a telemetric system to remotely and non-invasively measure
ICP. As sheep are quadrupeds however, some question remains
regarding the impact of head position, in particular when feeding,
on ICP measurements obtained using this method. Furthermore,
the use of individual cohorts of animals benefited this study
by allowing us to harvest the brain at specific time-points
following stroke and perform IHC accordingly, an important
aspect to understanding the evolution of the injury. The reliable
measurement of cerebral edema on MRI at a single time-point is
somewhat contentious, as the hyperintensity of vasogenic edema
is difficult to distinguish from the lesion itself. The measurement
of the entire FLAIR lesion volume therefore includes areas
of infarction as well as edema and is therefore an indirect
measure of edema volume. A more robust approach to measuring
edema would be to undergo sequential MRI’s and evaluate
the change in diffusion lesion volume between 2 time points
following reperfusion, which was not feasible in this study due
to cost. Furthermore, although GAD was utilized, T1 weighted
MRI images were only taken at a single time-point following
administration. As such, it is difficult to obtain a quantitative
measure of GAD extravasation across the barrier. A more robust
approach to this would be to obtain dynamic contrast enhanced
(DCE) and dynamic susceptibility contrast (DSC) sequences to
generate clinically relevant measurements of barrier permeability.
Finally, although gender differences were examined in this study
the hormonal status of the female animals at the time of stroke
and monitoring period was not known.
CONCLUSION
In this study, we have successfully developed a surgical approach
to tMCAO with reperfusion in the sheep that permits recovery
and the examination of long-term time-points following stroke.
In this novel model we have determined the temporal profile
of ICP, showing that ICP peaks at 5–6 days following stroke, in
conjunction with midline shift, an evolution of cerebral edema,
increased serum SP levels, enhanced SP immunoreactivity and
increased albumin extravasation. These results suggest a role of
SP in BBB disruption and the subsequent genesis of cerebral
edema and associated rise in ICP following stroke. As such,
agents targeting elevated ICP and cerebral edema would be
most effective when administered prior to 6 days post-stroke,
or as early as possible following stroke-onset. We conclude
that this ovine model provides a promising platform to screen
novel treatments targeting post-stroke complications and verify
treatment efficacy prior to clinical assessment.
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